We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900909:SSEShanghai Huayi Group Corporation Ltd. Class B Analysis

Data as of 2026-03-17 - not real-time

$0.56

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shanghai Huayi Group is trading well beneath its intrinsic valuation, offering a high dividend yield that comfortably exceeds the market average. Technical signals show a bullish price trend with the short‑term moving average above the medium‑term average and rising volume, while the MACD histogram remains slightly negative, suggesting some short‑term caution. Fundamentally, the company generates solid operating cash flow and maintains a strong cash cushion relative to its debt, supporting the dividend payout. However, margins are thin and revenue has contracted, indicating the need for operational improvements. The low beta and modest volatility point to a relatively stable price profile, though the small market cap and limited analyst coverage add liquidity and information risk. Overall, the stock presents a compelling income play with upside potential if the company can stabilize earnings and capitalize on its undervalued status.
Investors should weigh the attractive dividend and deep valuation gap against sector‑specific regulatory exposure and the modest growth outlook. In the near term, a cautious stance is prudent, but the medium‑term outlook improves as the valuation discrepancy widens and cash generation remains robust.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish moving‑average alignment
  • Increasing trading volume
  • MACD histogram still negative

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant gap between market price and intrinsic value
  • High, sustainable dividend yield
  • Strong cash generation relative to debt

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Structural undervaluation provides upside potential
  • Sector regulatory environment may constrain growth
  • Stable capital structure supports dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth-9.70%
Profit Margin1.44%
P/E Ratio13.9
ROE1.83%
ROA-0.26%
Debt/Equity42.01
P/B Ratio0.4
Op. Cash Flow$4.5B
Free Cash Flow$5.7B

Technical Analysis

TrendBullish
RSI51.4
Support$0.54
Resistance$0.58
MA 20$0.56
MA 50$0.54
MA 200$0.53
MACDBearish
VolumeIncreasing
Fear & Greed Index78.14

Valuation

Fair Value$19.88
GradeUndervalued
TypeValue
Dividend Yield4.49%

Risk Assessment

Beta0.10
Volatility19.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.